Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

04/03/2016 Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT 17/03/2015 Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement 17/09/2014 Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology 05/07/2013 Authors’ Submission Toolkit: a practical guide to getting your research published 04/07/2013 Reporting format for economic evaluation. Part II: Focus on modelling studies 04/07/2013 Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report 27/06/2013 Guidelines for field surveys of the quality of medicines: a proposal 21/06/2013 Anecdotes as evidence 20/06/2013 Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine 20/06/2013 Guidelines for submitting adverse event reports for publication

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More